S
Shanghai Bioscience
Providing consumables, reagents, instruments, and technical services for the life sciences industry
About Shanghai Bioscience
Founded in 2005, Shanghai Bioscience Co., Ltd. is a professional supplier of products and services for the life sciences sector in China. The company provides a broad portfolio of laboratory consumables, biological reagents, scientific instruments, and technical support services to research institutions, universities, pharmaceutical companies, and healthcare laboratories.
Shanghai Bioscience serves as the exclusive or primary distributor for several well-known international brands, helping bring advanced life science technologies and products to the Chinese market. Through these partnerships, the company ensures that its clients have access to high-quality, reliable solutions that support research and innovation across molecular biology, cell biology, immunology, and other life science disciplines.
In addition to distribution, Shanghai Bioscience continues to develop and expand its own proprietary product lines, with a focus on addressing local market needs and improving accessibility to essential research tools. Its offerings cover a range of applications, including PCR, ELISA, nucleic acid extraction, protein analysis, and laboratory automation.
The company also provides technical consultation and after-sales services, helping researchers select the appropriate tools for their work and ensuring proper implementation. By combining product distribution with application expertise, Shanghai Bioscience positions itself as not just a supplier, but a long-term partner to the scientific community.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2005
- Headquarters
- China
- Open positions
- 3
- Dealroom signal
- 21.3/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Medical Research, Biotech and Pharma, DT and LS, science-based
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Mar 2025 | $14M | $55M | Huagai Capital | ↗ |
Growth signals
Latest recorded traffic for Shanghai Bioscience is 230 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Huagai Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shanghai Bioscience on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shanghai Bioscience’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.